Stockreport

Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF MHLW approval makes VYLOY the first and only CLDN18.2-targeted therapy approved in the world TOKYO March 26, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, Pre [Read more]